Friday, June 12, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 161 of 1,261
  1. US 11801229

    Molecular entrapment via homopolymer self-assembly

    Northwestern University · Granted Oct 31, 2023 · Expires Oct 26, 2043

    granted
  2. US 11801295

    Immunogenic compositions and uses thereof

    The Board of Regents of the University of Texas System · Granted Oct 31, 2023 · Expires Oct 26, 2043

    granted
  3. US 11801288

    Cancer vaccines and methods of treatment using the same

    Inovio Pharmaceuticals, Inc. · Granted Oct 31, 2023 · Expires Oct 26, 2043

    granted
  4. US 11801268

    Methods of treating ocular inflammation and chemical injuries of the eye with extracellular vesicles

    Capricor, Inc. · Granted Oct 31, 2023 · Expires Oct 26, 2043

    granted
  5. US 11802158

    Bispecific anti-CD3 antibodies, bispecific activatable anti-CD3 antibodies, and methods of using the same

    CytomX Therapeutics, Inc. · Granted Oct 31, 2023 · Expires Oct 26, 2043

    granted
  6. US 11802138

    Optimized peptides for targeting human nerves and their use in image guided surgery, diagnostic and therapeutic delivery

    The Regents of the University of California · Granted Oct 31, 2023 · Expires Oct 26, 2043

    granted
  7. US 11801298

    MERS-CoV vaccine

    Inovio Pharmaceuticals, Inc. · Granted Oct 31, 2023 · Expires Oct 26, 2043

    granted
  8. US 11801257

    Stimulation of an immune response by enantiomers of cationic lipids

    PDS Biotechnology Corporation · Granted Oct 31, 2023 · Expires Oct 26, 2043

    granted
  9. US 11801241

    Muscarinic M2 receptor blockade to delay or prevent onset of progressive memory decline

    United States Government as represented by the Department of Veterans Affairs · Granted Oct 31, 2023 · Expires Oct 26, 2043

    granted
  10. US 11802283

    Oligonucleotide analogues targeting human LMNA

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Oct 31, 2023 · Expires Oct 26, 2043

    granted
  11. CA 3249631

    PROCÉDÉS ET COMPOSITIONS POUR RALENTIR LE DÉVELOPPEMENT DU DIABÈTE OU RÉDUIRE UN RISQUE DE DIABÈTE

    ABBOTT LAB · Granted Oct 26, 2023 · Expires Oct 21, 2043

    granted
  12. US 11793780

    Prodrugs of treprosiinil

    United Therapeutics Corporation · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted
  13. US 11795176

    Solid forms of Alpha-1062 gluconate

    ALPHA COGNITION INC. · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted
  14. US 11795235

    Immunotoxins with albumin binding domain

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted
  15. US 11793855

    TFPI inhibitors and methods of use

    Takeda Pharmaceutical Company Limited · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted
  16. US 11793860

    Vault complexes for cytokine delivery

    United States Government as represented by the Department of Veterans Affairs · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted
  17. US 11795457

    Compositions and methods for treatment of Friedreich's Ataxia

    The Board of Regents of the University of Texas System · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted
  18. US 11793772

    Pharmaceutical composition comprising THA as active ingredient for treating breast cancer

    KOREA UNITED PHARM. INC. · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted
  19. US 11793806

    Pyruvate kinase activators for use in therapy

    Agios Pharmaceuticals, Inc. · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted
  20. US 11795234

    Methods of producing muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide

    Dyne Therapeutics, Inc. · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted
  21. US 11795233

    Muscle-targeting complex comprising an anti-transferrin receptor antibody linked to an oligonucleotide

    Dyne Therapeutics, Inc. · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted
  22. US 11795232

    Engineered transferrin receptor binding polypeptides

    DENALI THERAPEUTICS INC. · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted
  23. US 11795216

    Antibodies neutralizing GM-CSF for use in the treatment of rheumatoid arthritis or as analgesics

    Takeda Pharmaceutical Company Limited · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted
  24. US 11795156

    Bicyclic carboxamides and methods of use thereof

    TEMPEST THERAPEUTICS, INC. · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.